摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-amino-2-thioxo-1,2,3,5,6,7-hexahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one

中文名称
——
中文别名
——
英文名称
3-amino-2-thioxo-1,2,3,5,6,7-hexahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one
英文别名
11-Amino-10-sulfanylidene-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(8),2(6)-dien-12-one;11-amino-10-sulfanylidene-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(8),2(6)-dien-12-one
3-amino-2-thioxo-1,2,3,5,6,7-hexahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one化学式
CAS
——
化学式
C9H9N3OS2
mdl
——
分子量
239.322
InChiKey
RKRJMMVORHRSKO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    15
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    119
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    3-amino-2-thioxo-1,2,3,5,6,7-hexahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one乙醇sodium 、 potassium hydroxide 作用下, 以 乙醇 为溶剂, 反应 8.0h, 生成 3-acetyl-1-(4-chlorophenyl)-1,7,8,9-tetrahydro-4H,6H-cyclopenta[4',5']thieno[2',3':4,5]pyrimido[1,2-b][1,2,4,5]tetrazin-6-one
    参考文献:
    名称:
    方便的一锅合成噻吩并[2',3':4,5]嘧啶[1,2-b]-[1,2,4,5]四嗪
    摘要:
    通过3-氨基-的反应制备了一系列新的噻吩并[2',3':4,5]嘧啶[1,2- b ] [1,2,4,5]四嗪-6-酮衍生物14。 2‐thioxo‐1,2,3,5,6,7‐hexahydro‐4 H ‐cyclopenta [4,5] thieno [2,3 ‐ d ]嘧啶‐4‐one 3或其甲硫基4与酰氯9。已经讨论了所研究反应的机理,并且有关产物指定结构的进一步证据是基于替代合成的。已对化合物14e进行了单晶X射线分析。
    DOI:
    10.1002/jhet.3117
  • 作为产物:
    描述:
    2-氨基-5,6-二氢-4H-环戊并[b]噻吩-3-甲酸乙酯 在 hydrazine hydrate 、 potassium hydroxide 作用下, 以 乙醇二甲基亚砜 为溶剂, 反应 20.25h, 生成 3-amino-2-thioxo-1,2,3,5,6,7-hexahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one
    参考文献:
    名称:
    方便的一锅合成噻吩并[2',3':4,5]嘧啶[1,2-b]-[1,2,4,5]四嗪
    摘要:
    通过3-氨基-的反应制备了一系列新的噻吩并[2',3':4,5]嘧啶[1,2- b ] [1,2,4,5]四嗪-6-酮衍生物14。 2‐thioxo‐1,2,3,5,6,7‐hexahydro‐4 H ‐cyclopenta [4,5] thieno [2,3 ‐ d ]嘧啶‐4‐one 3或其甲硫基4与酰氯9。已经讨论了所研究反应的机理,并且有关产物指定结构的进一步证据是基于替代合成的。已对化合物14e进行了单晶X射线分析。
    DOI:
    10.1002/jhet.3117
点击查看最新优质反应信息

文献信息

  • Click chemistry based synthesis, cytotoxic activity and molecular docking of novel triazole-thienopyrimidine hybrid glycosides targeting EGFR
    作者:Reham R. Khattab、Asma K. Alshamari、Allam A. Hassan、Hussein H. Elganzory、Wael A. El-Sayed、Hanem M. Awad、Eman S. Nossier、Nasser A. Hassan
    DOI:10.1080/14756366.2020.1871335
    日期:2021.1.1
    In the current study, new thienopyrimidine conjugates bearing 1,2,3-triazole core and different sugar moieties have been designed and synthesized by Cu(I)-catalysed click dipolar cycloaddition. The cytotoxic activity of the synthesised conjugates 2, 5, 7, and 13-18 was studied against HCT-116 and MCF-7 cell lines by the MTT assay. The triazole glycosides 16 and 18 provided significant cytotoxic activities against HCT-116 cell lines comparable to that of doxorubicin and other studied compounds. The cytotoxic behaviour against MCF-7 exhibited that all the investigated compounds were more potent than doxorubicin. Moreover, all screened targets were evaluated against mutant EGFR kinase type L858R and the results revealed that the acetylated 1,2,3-triazole glycosides 13-18 exhibited excellent EGFR inhibitory activity in comparison with gefitinib. Furthermore, molecular modelling studies were performed to investigate the binding affinity of the most active compounds to EGFR enzyme.
  • High potent and selective arylpiperazine derivatives as ligands for the 5-HT 1A receptor
    作者:Maria Modica、Maria Santagati、Andrea Santagati、Filippo Russo、Alfredo Cagnotto、Mara Goegan、Tiziana Mennini
    DOI:10.1016/s0960-894x(00)00165-7
    日期:2000.5
    This paper reports the synthesis and affinities on the 5HT(1A) versus the alpha(1)A receptors of new arylpiperazinylalkylthiothienopyrimidine and thiadiazole derivatives 16-24. Arylpiperazines 16-23 show affinities values in the nanomolar range for the 5HT(1A) receptor. The compound 16 is highly potent (K-i 0.26 nM, selectivity 28), the derivatives 20 and 21 are less potent, but highly selective (K-i 9.40 and 5.06 nM, selectivity 207 and 73, respectively). (C) 2000 Elsevier Science Ltd. All rights reserved.
  • A Convenient One-Pot Synthesis of Thieno[2′,3′:4,5]Pyrimido[1,2-b]-[1,2,4,5]Tetrazines
    作者:Allam A. Hassan、Reham R. Khattab、Ashraf A. F. Wasfy、Khadiga M. Abuzeid、Nasser A. Hassan
    DOI:10.1002/jhet.3117
    日期:2018.4
    A novel series of thieno[2′,3′:4,5]pyrimido[1,2‐b][1,2,4,5]tetrazin‐6‐one derivatives 14 were prepared from the reaction of 3‐amino‐2‐thioxo‐1,2,3,5,6,7‐hexahydro‐4H‐cyclopenta[4,5]thieno[2,3‐d]pyrimidin‐4‐one 3 or its methylthio 4 with hydrazonoyl chlorides 9. The mechanism of the studied reactions has been discussed and further evidence for the assigned structure of the products is based on alternative
    通过3-氨基-的反应制备了一系列新的噻吩并[2',3':4,5]嘧啶[1,2- b ] [1,2,4,5]四嗪-6-酮衍生物14。 2‐thioxo‐1,2,3,5,6,7‐hexahydro‐4 H ‐cyclopenta [4,5] thieno [2,3 ‐ d ]嘧啶‐4‐one 3或其甲硫基4与酰氯9。已经讨论了所研究反应的机理,并且有关产物指定结构的进一步证据是基于替代合成的。已对化合物14e进行了单晶X射线分析。
查看更多

同类化合物

林扎戈利 替普司特 噻吩并[3,4-d]嘧啶-2,4(1H,3H,5H,7H)-二酮 噻吩并[3,2-d]嘧啶-7-甲胺 噻吩并[3,2-d]嘧啶-4-羧酸 噻吩并[3,2-d]嘧啶-4(1H)-硫酮 噻吩并[3,2-d]嘧啶,4-(甲硫基)- 噻吩并[3,2-d]嘧啶 噻吩并[3,2-D]嘧啶-7-羧酸 噻吩并[3,2-D]嘧啶-7-甲醛 噻吩并[3,2-D]嘧啶-7-基甲醇 噻吩并[3,2-D]嘧啶-2-胺 噻吩并[2,3-d]嘧啶-4-胺 噻吩并[2,3-d]嘧啶-4-硫醇 噻吩并[2,3-d]嘧啶-4(3H)-酮 噻吩并[2,3-d]嘧啶-2,4-二胺 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(3-甲氧苯基)-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(3-氯苯基)-1-[(2,6-二氟苯基)甲基]-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(2-氯苯基)-1-[(2,6-二氟苯基)甲基]-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶 噻吩并[2,3-D]嘧啶-6-羧酸 噻吩并[2,3-D]嘧啶-6-甲醛 吡啶并[3’,2’:4,5]噻吩并[3,2-d]嘧啶-4(3h)-酮 乙基3-甲基-5-羰基-5H-[1]苯并噻吩并[2,3-d][1,3]噻唑并[3,2-a]嘧啶-2-羧酸酯 乙基2-(4-氯苯基)-7-甲基-9-羰基-9H-[1,3]噻唑并[3,2-a]噻吩并[3,2-d]嘧啶-6-羧酸酯 {[((4-氧代-3,4,5,6,7,8-六氢[1]苯并噻吩并[2,3-d]嘧啶-2-基)甲基]硫基}乙酸 [(6-甲基噻吩并[2,3-d]嘧啶-4-基)硫基]乙酸 [(4-氧代-3,4,5,6,7,8-六氢[1]苯并噻吩并[2,3-d]嘧啶-2-基)硫基]乙酸 PI3K抑制剂 PF-3758309抑制剂 Necrostatin-5; 2-[[3,4,5,6,7,8-六氢-3-(4-甲氧基苯基)-4-氧代[1]苯并噻吩并[2,3-d]嘧啶-2-基]硫代]-乙腈 N-甲基-1-噻吩并[3,2-d]嘧啶-4-基-4-哌啶甲胺 N-[2-[[3,4-二氢-4-氧代-3-[4-(2,2,2-三氟乙氧基)苯基]噻吩并[3,4-d]嘧啶-2-基]硫基]乙基]乙酰胺 N-[(1S)-2-(二甲基氨基)-1-苯基乙基]-2,6-二氢-6,6-二甲基-3-[(2-甲基噻吩并[3,2-d]嘧啶-4-基)氨基]-吡咯并[3,4-c]吡唑-5(4H)-甲酰胺盐酸盐 N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-3-(2-甲氧基苯基)-4-氧噻吩并[3,2-d]嘧啶-2-基)硫代]-乙酰胺 N-(4-氟苯基)-5,6-二甲基噻吩并[2,3-D]嘧啶-4-胺 N-(4-吗啉-4-基噻吩并[2,3-e]嘧啶-2-基)乙烷-1,2-二胺 N,N-二甲基-5,6,7,8-四氢苯并[4,5]噻吩并[2,3-D]嘧啶-4-胺 IWP2;N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-4-氧代-3-苯基噻吩并[3,2d]嘧啶-2-基)硫基]乙酰胺 AR-C 155858; (S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基]-5-[(4-羟基异噁唑烷-2-基)羰基]-1-异丁基-3-甲基噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮 7-甲基噻吩并[3,2-D]嘧啶-4-胺 7-甲基-噻吩并[3,2-d]嘧啶-2,4(1h,3h)-二酮 7-甲基-噻吩并[3,2-d]嘧啶 7-甲基-5,6,7,8-四氢[1]苯并噻吩并[2,3-d]嘧啶-4(3h)-酮 7-甲基-5,6,7,8-四氢-苯并[4,5]噻吩并[2,3-d]嘧啶-4-硫醇 7-溴噻吩并[3,2-d]嘧啶 7-溴噻吩并[3,2-D]嘧啶-4(1H)-酮 7-溴-噻吩并[3,2-d]嘧啶-4-胺 7-溴-4-氯噻酚并[3,2-D]嘧啶 7-溴-2-氯噻吩并[3,2-D]嘧啶